AbbVie ABBV Other Aesthetics — Net revenues

Other product segments

Similar metrics at other companies

EOLSProduct revenue, net — Total net revenues

$72.75M+6.9%

OSUROther — Net revenues

$1.55M+65.8%

FLWSOther Revenues — Net revenues

$43.22M+8.9%

EXFYOther — Revenue, net

$119K+67.6%

OSUROther Product And Services Revenues — Net revenues

$1.62M+109%

MRCYOther — Net revenues

$43.94M-6.0%

Questions, answered.

What is AbbVie's other aesthetics — net revenues?

AbbVie (ABBV) reported other aesthetics — net revenues of $309M in Q2 2026.

How has AbbVie's other aesthetics — net revenues changed year-over-year?

AbbVie's other aesthetics — net revenues decreased by 5.5% year-over-year, from $327M to $309M.

What is the long-term trend for AbbVie's other aesthetics — net revenues?

Over 4 years (2021 to 2025), AbbVie's other aesthetics — net revenues has grown at a -3.6% compound annual growth rate (CAGR), from $1.47B to $1.27B.

What does other aesthetics — net revenues mean?

This metric represents the total net sales generated from the company's secondary portfolio of aesthetic products, excluding primary flagship brands. It reflects the revenue contribution from niche or emerging aesthetic treatments and medical devices within the broader aesthetics business unit. Monitoring this stream helps investors assess the diversification and growth potential of the company's non-core aesthetic offerings.